Enaminones-versatile therapeutic pharmacophores. Further advances

Current Medicinal Chemistry

Volumn 7, Issue 4, 2000, Pages 417-436

  Eddington, N D ^a   Cox, D S ^a   Roberts, R R ^b   Stables, J P ^c   Powell, C B ^d   Scott, K R ^e  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b 3M COMPANY   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d EMORY UNIVERSITY   (United States)

^e HOWARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ENAMINONE DERIVATIVE; METHYL 4 [(CHLOROPHENYL)AMINO] 6 METHYL 2 OXO CYCLOHEX 3 EN 1 OATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTICONVULSANT ACTIVITY; DRUG EFFECT; DRUG SYNTHESIS; DRUG USE; MOUSE; NONHUMAN; PHARMACOPHORE; REVIEW;

EID: 0034083195     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867003375092     Document Type: Review

References (78)

1. Blache, Y.; Sinibaldi-Troin, M.-E.; Voldoire, A.; Chavignon, O.; Gramain, J.-C.; Teulade, J.-C.; Chapat, J.-P. J. Org. Chem. 1997, 62, 8553.
2. Takeya, K.; Itoigawa, M.; Furukawa, H. Eur. J. Pharmacol. 1989, 169, 137.
3. Kordik, C.P.; Reitz, A.B. J. Org. Chem. 1996, 61, 5644.
4. Maryanoff, B.E.; Ho, W.; McComsey, D.F.; Reitz, A.B.; Grous, P.P.; Nortey, S.O.; Shank, R.P.; Dubinsky, B.; Taylor, R.J., Jr.; Gardocki, J.F. J. Med. Chem. 1995, 38, 16.
5. Greenhill, J.V. Chem. Soc. Rev. 1977, 6, 277.
6. Haight, A.R.; Stuk, T.L.; Allen, M.S.; Bhagavatula, L.; Fitzgerald, M.; Hannick, S.M.; Kerdesky, F.A.J.; Menzia, J.A.; Parekh, S.I.; Robbins, T.A.; Scarpetti, D.; Tien, J.-H.J. Org. Proc. Res. Dev. 1999, 3, 94.
7. Edafiogho, I.O.; Alexander, M.S.; Moore, J.A.; Farrar, V.A., Scott, K.R. Current Med. Chem. 1994, 1, 159.
8. Suzuki, K.; Komatsu, T.; Ine, S.; Fujii, K.; Kojima, J.; Yamana, K. Jpn. Kokai Tokkyo Koho JP 04, 282, 314 [92,282,314] , 7 Oct 1992; Chem. Abstr. 1993, 118, 73688v.
9. Miyano, S.; Abe, N. U.S. Patent 3,969,409, July 13, 1976.
10. Dannhardt, G.; Dominiak, P.; Laufer, S. Arzneim.-Forsch./Drug Res. 1993, 43, 441.
11. Dannhardt, G.; Bauer, A.; Nowe, U. Arch. Pharm. Pharm. Med. Chem. 1997, 330, 74.
12. Dannhardt, G.; Bauer, A.; Nowe, U. J. prakt. Chem. 1998, 340, 256.
13. Liebischer, J.; Patzel, M. Synlett. 1994, 471.
14. Edafiogho, I.O.; Muhammad, B.Y.; Unekwe, P.C. Nigerian J. Basic Appl. Sci. 1989, 3, 35.
15. Edafiogho, I.O. Pharm. World J. 1990, 7, 20.
16. Dominguez, J.N.; Lopez, S.; Charris, J.; Iarruso, L.; Lobo, G.; Semenov, A.; Olsen, J.E.; Rosenthal, P.J. J. Med. Chem. 1998, 40, 2726.
17. Craig, P. N. J. Med. Chem. 1971, 14, 680.
18. Craig, P.N. J. Med. Chem. 1972, 15, 144.
19. Scott, K.R.; Rankin, G.O.; Stables, J.P.; Alexander, M.S.; Edafiogho, I.O.; Farrar, V.A.; Kolen, K.R.; Moore, J.A.; Sims, I.D.; Tonnu, A.D. J. Med. Chem. 1995, 38, 4033.
20. Kase' Y; Saita, M.; Takahama, K.; Masaki, K.; Miyata, T. Jpn. J. Pharmacol. 1974, 24 (Suppl.), 86.
21. Craig, P.N., Unpublished observations.
22. Taft, R.W., Jr. J. Phys. Chem. 1960, 64, 1805.
23. Roberts, J.D.; Carboni, R.A. J. Am. Chem. Soc. 1955, 77, 5554.
24. Newman, M.S.; Merrill, S.H. J. Am. Chem. Soc. 1955, 77, 5552.
25. McDaniel, D.H.; Brown, H.C. J. Am. Chem. Soc. 1955, 77, 3756.
26. Edafiogho, I.O.; Moore, J.A.; Alexander, M.S.; Scott, K.R. J. Pharm. Sci. 1994, 83, 1155.
27. Zhou, J.-C. Magnetic Resonance Chem. 1998, 36, 565.
28. Edafiogho, I.O.; Hinko, C.N.; Chang, H.; Moore, J.A.; Mulzac, D.; Nicholson, J.M.; Scott, K.R. J. Med. Chem. 1992, 35, 2799.
29. Mulzac, D.; Scott, K.R. Epilepsia 1993, 36, 1141.
30. Scott, K.R.; Edafiogho, I.O.; Richardson, E.L.; Farrar, V.A.; Moore, J.A.; Tietz, E.I.; Hinko, C.N.; Chang, H.; El-Assadi, A.; Nicholson, J.M. J. Med. Chem. 1993, 36, 1947.
31. Lin, Z.W.; Kadaba, P.K. Med. Res. Rev. 1997, 17, 537.
32. (a) Catterall, W.A. Trends Pharmacol. Sci. 1987, 8, 57.
33. (b) Willow, M.; Kuenzel, E.A.; Catterall, W.A. Mol. Pharmacol. 1982, 25, 228.
34. Willow, M.; Catterall, W.A. Mol. Pharmacol. 1982, 22, 627.
35. rd ed.; Levy, R.H., Dreifuss, F.E., Mattson, R.H., Meldrum, B.S., Penry, J.K., Eds.; Raven Press: New York, 1989; pp 85-102.
36. Cheung, H.; Kamp, D.; Harris, E. Epilepsy Res. 1992, 13, 107.
37. Miller, A.A.; Wheatley, P.; Sawyer, D.A.; Baxter, M.G.; Roth, B. Epilepsia 1986, 27, 483.
38. (a) Creveling, C.R. Mol. Pharmacol. 1983, 23, 350.
39. (b) Trainer, V.L.; Moreau, E.; Guedin, D.; Baden, D.G.; Catterall, W.A. J. Biol. Chem. 1993, 268, 17114.
40. Roberts, R.R.; Edafiogho, I.O.; Scott, K.R. US Patent No. 5,580,894 1996.
41. Miyano, S.; Abe, N.; Sumoto, K. J. Chem. Soc. Chem. Comm. 1975, 760.
42. Laws, M.L.; Roberts, R.R.; Nicholson, J.M.; Butcher, R.; Stables, J.P.; Goodwin, A.M.; Smith, C.A.; Scott, K.R. Bioorg. Med. Chem. 1998, 6, 2289.
43. Mital, R.; Jain, S.K. J. Chem. Soc. (C) 1969, 2148.
44. Alaimo, R.J. J. Heterocyclic Chem. 1971, 8, 309.
45. Gupta, R.R.; Ojha, K.G.; Kumar, M.J. J. Heterocyclic Chem. 1980, 17, 803.
46. Carson, J.R.; Carmosin, R.J.; Pitis, P.M.; Vaught, J.L.; Almond, H.R.; Stables, J.P.; Wolf, H.H.; Swinyard, E.A.; White, H.S. J. Med. Chem. 1997, 40, 1578.
47. Jones, R.A.; Bean, G.P. The Chemistry of the Pyrroles, Academic Press: New York, 1977; pp 284-289.
48. nd ed.; Marcel Dekker, Inc.: New York, 1988; pp 16-17.
49. Unverferth, K.; Engel, J.; Hofgen, N.; Rostock, A.; Gunther, R.; Lankau, H.-J; Manzer, M.; Rolfs, A.; Liebscher, J.; Muller, B.; Hofmann, H.-J. J. Med Chem. 1998, 41, 1578.
50. th ed.; Wolff, M.E., Ed.; J. Wiley and Sons, Inc.: New York, 1996; pp 175-160.
51. (b) Musso, D.L.; Boswell, G.E.; Mehta, N.B.; Soroko, F.E.; Burchall, C.J. Bur. J. Med. Chem. 1996, 31, 331.
52. (c) Moreau, S.; Coudert, P.; Rubat, C.; Vallee-Goyet, D.; Gardette, D.; Gramain, J.-C.; Couquelet, J. Bioorg. Med. Chem. 1998, 6, 983.
53. (d) Michon, V.; Herve du Penhoat, C.; Tombret, F.; Gillardin, J.M.; Lepage, F.; Berthon, L. Eur. J. Med. Chem. 1995, 30, 147.
54. Foster, J.E.; Nicholson, J.M.; Butcher, R.; Stables, J.P.; Edafiogho, I.O.; Goodwin, A.M.; Henson, M.C.; Smith, C.A.; Scott, K.R. Bioorg. Med Chem. (accepted).
55. Kubicki, M.; Codding, P.W. Acta Cryst 1993, C49, 2045.
56. MacLogP Program; version 2.0 BioByte Corp. Claremont, CA 91711.
57. Spartan SGI Version 4.1.1, Wavefunction, Inc., 18401 Von Karman Ave., #370, Irvine, CA 92715. © 1991-1996 Wavefunction Inc.
58. SYBYL, Version 6.04, Tripos Associates, Inc., 1699 S. Hanley Road, St. Louis, MO 63144.
59. Zymalkowski, F.; Rimek, H. Archiv der Pharmazie, 1961, 294, 759.
60. Rosowsky, A.; Forsch, R A.; Moran, R.G. J. Med. Chem. 1991, 34. 463.
61. Banks, W.A.; Kastin, A.J. Brain Res. Bull. 1985, 15, 287.
62. Van Bree, J.B.; de Boer, A.G.; Danhog, M.; Ginsel, L.A.; Breimer, D.D. J. Pharmacol. Exp. Ther. 1988, 247, 1233.
63. Shah, M.V.; Audus, K.L.; Borchardt, R.T. Pharm. Res. 1989, 6, 624.
64. Pardridge, W.M. Adv. Drug Del Rev. 1995, 15, 5.
65. Eddy, E.P.; Maleef, B.E.; Hart, T.K.; Smith, P.L. Adv. Drug Del. Rev. 1997, 23, 184.
66. Audus, K.L.; Borchardt, R.T. Ann. N.Y. Acad. Sci. 1987, 507, 9.
67. Couraud, P.; Scherman, D. Biology and Physiology of the Blood-Brain Barrier. Transport, Cellular Interaction, and Brain Pathologies, Plenum Press, New York, 1996.
68. Audus, K.L.; Borchardt, R.T. Pharm. Res. 1986, 3, 81.
69. Shi, F.; Bailey, C.; Malick, A.; Audus, K.L. Pharm. Res. 1985, 2, 282.
70. Rose, J.M.; Audus, K.L. S. T. P. Pharm. Sci. 1997, 7, 71.
71. Courtney, K.R. J. Pharmacol. Exp. Ther. 1980, 213, 114.
72. Barbato, F.; La Rotonda, M.; Quaglia, F. Pharm. Res. 1997, 14, 1699.
73. Cox, D.S.; Scott, K.R.; Eddington, N.D. Pharm. Sci. 1998, 1, S-398.
74. Hansch, C.; Leo, A. Exploring QSAR-Fundamentals and Applications in Chemistry and Biology, American Chemical Society: Washington, DC, 1995, pp 535-543.
75. Li, W.-Y., Quo, Z.-R., Lien, E.J. J. Pharm. Sci. 1984, 73, 553
76. Brown, M.L., Brown, G.B.; Brouillette, W.J. J. Med. Chem. 1997, 40, 602.
77. Brown, M.L., Zha, C.C., Van Dyke, C.D., Brown, G.B., Brouillette, W.J. J. Med. Chem. 1999, 42, 1537.
78. Craig, P.N.; Hansch, C.H.; McFarland, J.W.; Martin, Y.C.; Purcell, W.P.; Zahradnik, R. J. Med. Chem. 1971, 14, 447.